We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Invitae Corporation | NYSE:NVTA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0891 | 0 | 01:00:00 |
-- 14 posters and presentations to focus on advances in genetic testing technology and medical interpretation tools as well as new applications of genetics in health and wellness --
This week Invitae Corporation (NYSE: NVTA), a genetic information company, is presenting multiple abstracts at the American Society of Human Genetics (ASHG) 2016 Annual Meeting in Vancouver, covering an array of topics in genetics, including advances in complex variant detection and medical interpretation, as well as survey data exploring the attitudes of healthy adults seeking genetic testing through their physicians and the frequency with which medical guidance accompanies the results.
“The use of genetic information to better understand and diagnose disease and to guide treatment choices expands significantly each year,” said Robert Nussbaum, MD, chief medical officer of Invitae. “The research presented at this year’s ASHG meeting moves us another step forward in our scientific knowledge and understanding of how individuals and their physicians think about genetic testing and its utility. Invitae is steadfast in our commitment to provide high quality genetic information to our physicians and patients, and by leading with science, we believe we can help individuals and their physicians make informed health decisions based on their genetic information.”
Among Invitae’s ASHG presentations:
The full schedule of Invitae posters and presentations is as follows:
Wednesday, October 19, 2:00-4:00 pm
Thursday, October 20, 2:00-4:00 pm
Friday, October 21, 2:00-4:00 pm
For additional information on Invitae’s presence at ASHG, please visit https://www.invitae.com/ashg2016/.
About Invitae
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. For more information, visit our website at invitae.com.
Safe Harbor Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the use of research and the company’s ability to help individuals and their physicians make informed health decisions based on their genetic information, the company’s belief that the use of genetic information to guide treatment expands significantly each year, the utility of genetic testing and its impact on diagnoses and patient outcomes, and the applicability and utility of the research studies to diagnoses and patient outcomes. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks associated with the company’s ability to use rapidly changing genetic data to interpret test results accurately and consistently; the company’s ability to develop tests to keep pace with rapidly changing technology and new and increasing amounts of scientific data; laws and regulations applicable to the company’s business, including potential regulation by the Food and Drug Administration; the company’s ability to develop and commercialize new tests and expand into new markets; and the other risks set forth in the company’s filings with the Securities and Exchange Commission, including the risks set forth in the company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016. These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.
NOTE: Invitae and the Invitae logo are trademarks of Invitae Corporation. All other trademarks and service marks are the property of their respective owners.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161019005419/en/
Invitae CorporationLaura D’Angelo, 314-920-0617pr@invitae.com
1 Year Invitae Chart |
1 Month Invitae Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions